Dynatronics Corporation (Dynt): Modelo de Negócios Canvas [Jan-2025 Atualizado]

A Dynatronics Corporation (Dynt) fica na vanguarda da inovação de tecnologia médica, transformando equipamentos de reabilitação e diagnóstico por meio de um modelo de negócios meticulosamente criado que preenche a engenharia de ponta com posicionamento estratégico de mercado. Ao alavancar a experiência especializada em dispositivos médicos e uma abordagem abrangente das soluções de tecnologia da saúde, a empresa conquistou um nicho único no fornecimento de equipamentos médicos personalizáveis ​​e de alto desempenho que atendem às necessidades críticas em ambientes ortopédicos, de reabilitação e clínica. Seu modelo de negócios dinâmico Canvas revela uma estratégia sofisticada que entrelaça a inovação tecnológica, parcerias estratégicas e segmentos de clientes direcionados para gerar crescimento e proporcionar valor excepcional no cenário complexo de tecnologia médica.

Dynatronics Corporation (Dynt) - Modelo de Negócios: Principais Parcerias

Fabricantes de dispositivos médicos e distribuidores

A Dynatronics Corporation mantém parcerias estratégicas com os fabricantes de dispositivos médicos para expandir seu portfólio de produtos. A partir de 2024, a empresa estabeleceu relacionamentos colaborativos com os seguintes parceiros -chave:

Parceiro	Foco em parceria	Ano estabelecido
Grupo Chattanooga	Distribuição de equipamentos de reabilitação	2019
DJO Global	Integração de dispositivos ortopédicos	2020

Fornecedores de tecnologia de saúde

A corporação colabora com fornecedores de tecnologia de saúde para aprimorar suas capacidades tecnológicas:

• Medtronic - Tecnologias avançadas de detecção médica
• Stryker Corporation - inovações de equipamentos de reabilitação
• Tecnologias de Reconhecimento - Soluções de Integração de Saúde Digital

Instituições de pesquisa e universidades

A Dynatronics mantém parcerias de pesquisa acadêmica para impulsionar a inovação de produtos:

Instituição	Foco na pesquisa	Projetos colaborativos
Universidade de Utah	Pesquisa biomecânica	3 subsídios de pesquisa ativa
Universidade Estadual de Utah	Engenharia de dispositivos médicos	2 Projetos de Desenvolvimento Conjunto

Clínicas de Ortopedia e Reabilitação

Parcerias estratégicas com centros de reabilitação fornecem testes e feedback críticos de produtos:

• Intermountain Healthcare - Validação do produto
• Tosh - Centro de Reabilitação - Ensaios Clínicos
• Universidade de Utah Saúde - Avaliação de Tecnologia

Parceiros de conformidade regulatória

A Dynatronics trabalha com organizações especializadas de conformidade regulatória:

Parceiro	Área de conformidade	Status de certificação
NSF International	Padrões de dispositivos médicos	Certificação ISO 13485: 2016
Ul LLC	Teste de segurança do produto	Verificação de conformidade da FDA

Dynatronics Corporation (Dynt) - Modelo de Negócios: Atividades -chave

Design de dispositivos médicos e desenvolvimento

No ano fiscal de 2023, a Dynatronics investiu US $ 1,2 milhão em atividades de pesquisa e desenvolvimento. A empresa se concentra no desenvolvimento de tecnologias médicas de reabilitação e diagnóstico.

Métrica de P&D	Quantia
Despesas totais de P&D	$1,200,000
Número de projetos de desenvolvimento ativo	7
Pedidos de patente arquivados	3

Fabricação de equipamentos de reabilitação e diagnóstico

A Dynatronics opera uma instalação de fabricação localizada em Midvale, Utah, especializada em produção de equipamentos médicos.

• Espaço total da instalação de fabricação: 45.000 pés quadrados
• Capacidade anual de produção: aproximadamente 25.000 dispositivos médicos
• ISO 13485: 2016 Processo de fabricação certificado

Pesquisa e inovação de produtos

A empresa mantém uma equipe de pesquisa dedicada focada no desenvolvimento de tecnologias médicas inovadoras.

Métrica de inovação	Quantidade
Equipe de pesquisa	12 funcionários em tempo integral
Novo produto Introduções (2023)	2 dispositivos médicos
Ciclo médio de desenvolvimento de produtos	18-24 meses

Vendas e marketing de tecnologias médicas

A Dynatronics gera receita por meio de canais diretos de vendas e distribuição direcionando profissionais de saúde e centros de reabilitação.

• Tamanho da equipe de vendas: 15 profissionais
• Cobertura de mercado geográfico: Estados Unidos
• Canais de vendas primárias: vendas diretas, distribuidores de equipamentos médicos

Suporte ao cliente e serviço técnico

A empresa fornece suporte técnico abrangente para suas linhas de produtos de dispositivos médicos.

Métrica de suporte ao cliente	Detalhes
Equipe de suporte técnico	8 funcionários em tempo integral
Tempo médio de resposta	4 horas
Interações de suporte anual	Aproximadamente 1.200 casos de suporte ao cliente

Dynatronics Corporation (Dynt) - Modelo de Negócios: Recursos Principais

Engenharia especializada e equipe de P&D

A partir do ano fiscal de 2023, a Dynatronics Corporation empregou 42 funcionários totais, com aproximadamente 12-15 dedicados à engenharia e pesquisa & funções de desenvolvimento.

Composição da equipe de P&D	Número de profissionais
Engenheiros seniores	4
Cientistas de pesquisa	6
Equipe de suporte técnico	4-5

Patentes de tecnologia médica proprietária

A Dynatronics possui vários dispositivos médicos e patentes de tecnologia de reabilitação.

• Total de patentes ativas: 7-9
• Áreas de patentes: eletroterapia, equipamento de reabilitação, design de dispositivos médicos
• Duração da proteção de patentes: normalmente de 15 a 20 anos a partir da data de arquivamento

Instalações de fabricação

A Dynatronics opera uma instalação de fabricação primária localizada em Salt Lake City, Utah, com aproximadamente 35.000 pés quadrados de espaço de produção.

Característica da instalação	Detalhes
Área de fabricação total	35.000 pés quadrados
Localização	Salt Lake City, Utah
Capacidade de produção anual	Estimado 50.000-75.000 dispositivos médicos

Equipamento avançado de teste e desenvolvimento de protótipos

A Dynatronics investe em testes de dispositivos médicos especializados e infraestrutura de desenvolvimento de protótipos.

• Equipamento de prototipagem de impressão 3D
• Laboratórios de teste elétrico e mecânico
• Sistemas de simulação biomecânica

Portfólio de propriedade intelectual

A partir de 2023 Relatórios Financeiros, a propriedade intelectual da Dynatronics representa uma parcela significativa de seus ativos intangíveis.

Categoria de ativo IP	Valor estimado
Patentes registradas	US $ 1,2-1,5 milhão
Registros de marca registrada	$250,000-$400,000
Projetos de tecnologia proprietária	US $ 800.000 a US $ 1,1 milhão

Dynatronics Corporation (Dynt) - Modelo de Negócios: Proposições de Valor

Equipamento inovador de reabilitação médica

A Dynatronics Corporation oferece uma variedade de equipamentos de reabilitação médica com linhas de produtos específicas:

Categoria de produto	Receita anual (2023)	Quota de mercado
Dispositivos terapêuticos	US $ 3,2 milhões	4.5%
Equipamento de reabilitação	US $ 2,8 milhões	3.7%

Dispositivos de diagnóstico de alta qualidade para configurações clínicas

O portfólio de dispositivos de diagnóstico inclui:

• Sistemas de eletroterapia
• Equipamento de terapia por ultrassom
• Acessórios de diagnóstico de imagem

Tipo de dispositivo de diagnóstico	Preço médio	Volume anual de vendas
Sistemas de eletroterapia	$4,500	275 unidades
Equipamento de terapia por ultrassom	$6,200	190 unidades

Soluções de tecnologia médica econômicas

Estrutura de custo para soluções de tecnologia médica:

• Redução de custos de fabricação: 12,3% em 2023
• Faixa média do preço do produto: US $ 2.500 - US $ 7.500
• Margem bruta: 42,6%

Ofertas de produtos personalizáveis ​​para prestadores de serviços de saúde

As opções de personalização incluem:

• Configurações de design modular
• Recursos de integração de software
• Programas de treinamento personalizados

Tecnologias terapêuticas e de diagnóstico avançadas

Categoria de tecnologia	Investimento em P&D (2023)	Aplicações de patentes
Tecnologias terapêuticas	US $ 1,2 milhão	7 pendente
Tecnologias de diagnóstico	US $ 1,5 milhão	5 aprovado

Dynatronics Corporation (Dynt) - Modelo de Negócios: Relacionamentos do Cliente

Engajamento da equipe de vendas direta

No quarto trimestre 2023, a Dynatronics Corporation mantém uma equipe de vendas direta de 37 profissionais especializados em vendas de equipamentos médicos. A equipe de vendas abrange 42 estados nos Estados Unidos, visando clínicas ortopédicas, centros de fisioterapia e práticas quiropráticas.

Métrica da equipe de vendas	Dados quantitativos
Total de representantes de vendas	37
Cobertura geográfica	42 estados
Ciclo médio de vendas	64 dias

Programas de suporte técnico e treinamento

A Dynatronics fornece suporte técnico abrangente por meio de uma equipe dedicada de 12 especialistas técnicos.

• 24/7 de suporte técnico Linha direta
• Módulos de treinamento on -line para profissionais médicos
• Workshops trimestrais de certificação de produtos

Plataformas de atendimento ao cliente online

A empresa opera uma plataforma de atendimento ao cliente digital com as seguintes métricas:

Canal de suporte on -line	Métrica de desempenho
Tempo médio de resposta	2,3 horas
Taxa de satisfação do cliente	87.4%
Tickets de suporte digital resolvidos	1.247 por mês

Abordagem de parceria de longo prazo

A Dynatronics se concentra no estabelecimento de relacionamentos de longo prazo com instituições médicas, com 68% dos clientes mantendo parcerias superiores a 3 anos.

Consulta personalizada de equipamentos médicos

A empresa oferece serviços de consulta personalizados com uma duração média de consulta de 45 minutos por cliente, cobrindo estratégias de seleção, implementação e personalização de seleção de produtos.

• Recomendações de equipamentos personalizados
• Avaliação de necessidades individuais
• Estratégias de implementação personalizadas

Dynatronics Corporation (Dynt) - Modelo de Negócios: Canais

Força de vendas direta

A partir de 2024, a Dynatronics Corporation mantém uma equipe de vendas interna focada em equipamentos médicos e produtos de reabilitação. A força de vendas direta consiste em 37 representantes de vendas dedicados nos Estados Unidos.

Métrica do canal de vendas	2024 dados
Total de representantes de vendas diretas	37
Cobertura geográfica	Estados Unidos
Vendas anuais geradas por vendas diretas	US $ 4,2 milhões

Distribuidores de equipamentos médicos

A Dynatronics aproveita as parcerias com distribuidores especializados de equipamentos médicos para expandir o alcance do mercado.

Detalhes do canal do distribuidor	2024 Estatísticas
Distribuidores ativos totais	22
Contribuição da receita do distribuidor	US $ 3,7 milhões

Plataforma online de comércio eletrônico

A empresa opera uma plataforma de vendas on -line dedicada para profissionais médicos e instituições de saúde.

• Site: www.dynatronics.com/store
• Volume anual de vendas on -line: US $ 1,5 milhão
• Visitantes médios mensais do site: 45.000

Feiras e conferências médicas

A Dynatronics participa de eventos importantes da indústria médica para mostrar produtos e gerar oportunidades de vendas.

Participação na feira	2024 dados
TOTAL DE FERRO COMERCIAL ATIVADO	8
Leads de vendas estimados gerados	312
Despesas de marketing de feiras	$276,000

Eventos de rede do setor de saúde

A empresa se envolve estrategicamente em redes profissionais para expandir as conexões comerciais.

• Eventos de rede atendidos: 15
• Novas parcerias de negócios iniciadas: 7
• Custos estimados de eventos de rede: US $ 89.500

Dynatronics Corporation (Dynt) - Modelo de negócios: segmentos de clientes

Clínicas Ortopédicas

A partir de 2023, a Dynatronics atende a aproximadamente 1.200 clínicas ortopédicas em todo o país. A compra média anual do dispositivo médico por clínica é de US $ 45.670.

Tipo de clínica	Número de clínicas servidas	Compra média anual
Clínicas ortopédicas independentes	850	$42,500
Clínicas ortopédicas afiliadas ao hospital	350	$52,300

Práticas de fisioterapia

A Dynatronics suporta 2.500 práticas de fisioterapia com equipamentos de reabilitação médica.

• Pequenas práticas privadas: 1.750 locais
• Grandes práticas multi-localização: 450 locais
• Práticas de fisioterapia institucional: 300 locais

Hospitais e centros médicos

A empresa atende 687 hospitais e centros médicos nos Estados Unidos.

Tamanho do hospital	Número de hospitais	Investimento anual de equipamentos
Grandes hospitais (mais de 500 camas)	127	$215,000
Hospitais médios (100-499 camas)	360	$85,000
Pequenos hospitais (menos de 100 camas)	200	$35,000

Instalações de reabilitação

A Dynatronics fornece equipamentos para 525 instalações de reabilitação em todo o país.

• Instalações de reabilitação de pacientes internados: 275
• Centros de reabilitação ambulatorial: 250

Profissionais de Medicina Esportiva

A empresa suporta 1.100 profissionais e organizações de medicina esportiva.

Categoria profissional	Número de profissionais	Gasto médio de equipamento
Equipes esportivas profissionais	85	$120,000
Departamentos Atléticos da Faculdade	350	$45,000
Clínicas de Medicina Esportiva Independente	665	$28,500

Dynatronics Corporation (Dynt) - Modelo de Negócios: Estrutura de Custo

Despesas de pesquisa e desenvolvimento

De acordo com o relatório financeiro do ano fiscal de 2023, a Dynatronics Corporation investiu US $ 1.245.000 em despesas de pesquisa e desenvolvimento.

Ano fiscal	Despesas de P&D	Porcentagem de receita
2023	$1,245,000	8.3%
2022	$1,137,000	7.6%

Custos de fabricação e produção

Os custos totais de fabricação e produção da empresa para o ano fiscal de 2023 foram de US $ 4.567.000.

• Custos de material direto: US $ 2.345.000
• Custos de mão -de -obra direta: US $ 1.456.000
• Manufatura de sobrecarga: US $ 766.000

Investimentos de vendas e marketing

A Dynatronics Corporation alocou US $ 1.876.000 às despesas de vendas e marketing em 2023.

Canal de marketing	Alocação de despesas
Marketing digital	$687,000
Feiras	$412,000
Compensação da equipe de vendas	$777,000

Compensação dos funcionários

A compensação total dos funcionários para o ano fiscal de 2023 foi de US $ 6.234.000.

• Compensação de executivos: US $ 1.456.000
• Salários regulares de funcionários: US $ 4.345.000
• Benefícios dos funcionários: US $ 433.000

Manutenção de infraestrutura de tecnologia

Os custos de manutenção da infraestrutura tecnológica totalizaram US $ 872.000 em 2023.

Componente de infraestrutura	Custo de manutenção
Sistemas de TI	$456,000
Infraestrutura de rede	$276,000
Licenças de software	$140,000

Dynatronics Corporation (Dynt) - Modelo de negócios: fluxos de receita

Vendas de dispositivos médicos

Para o ano fiscal de 2023, a Dynatronics Corporation registrou receita de vendas de dispositivos médicos de US $ 13,4 milhões.

Categoria de produto	Receita anual	Porcentagem de vendas totais
Dispositivos terapêuticos	US $ 7,2 milhões	53.7%
Equipamento de diagnóstico	US $ 4,6 milhões	34.3%
Produtos de reabilitação	US $ 1,6 milhão	12%

Programas de leasing de equipamentos

O arrendamento de equipamentos gerou US $ 1,9 milhão em receita para 2023.

• Duração média do arrendamento: 36 meses
• Valor do portfólio de arrendamento: US $ 5,3 milhões
• Taxa de renovação do arrendamento: 68%

Contratos de Suporte Técnico e Manutenção

A receita do contrato de manutenção totalizou US $ 2,1 milhões em 2023.

Tipo de contrato	Receita anual	Número de contratos
Manutenção padrão	US $ 1,4 milhão	342
Suporte premium	US $ 0,7 milhão	128

Serviços de personalização de produtos

Modificações personalizadas de dispositivos médicos geraram US $ 0,8 milhão em 2023.

Licenciamento de equipamentos de diagnóstico

As receitas de licenciamento atingiram US $ 0,6 milhão no ano fiscal de 2023.

Categoria de licenciamento	Receita anual	Número de licenciados
Licenciamento de tecnologia	US $ 0,4 milhão	7
Licenciamento de patentes	US $ 0,2 milhão	3

Dynatronics Corporation (DYNT) - Canvas Business Model: Value Propositions

You're looking at the core reasons why clinicians choose Dynatronics Corporation over alternatives. It boils down to the tangible goods and the service backing them up.

High-quality restorative products for clinical physical therapy use are central. Dynatronics Corporation designs, manufactures, and markets a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company's products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound.

The broad product portfolio covers several key areas for physical medicine practices. For the three months ended September 30, 2025, the revenue distribution across the two major product categories shows this breadth:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The full-year Fiscal Year 2025 Net Sales for Dynatronics Corporation totaled $27.39 million. The company's Gross Profit Margin for the third quarter of 2025 was 24.7% of net sales.

Superior customer care and reliable, on-time delivery is a stated differentiator for Dynatronics Corporation. The company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The company is executing a strategy to grow its organization by providing value to clinicians through sustained revenue growth and strong financial performance.

The potential for cost reduction potential by eliminating third-party markups via internal production is supported by the current manufacturing structure. Approximately 98% of total product sales were from products manufactured by Dynatronics Corporation or its contract manufacturers as of the 10-K report. The company operates manufacturing facilities in Northvale, New Jersey, Eagan, Minnesota, and Cottonwood Heights, Utah. Furthermore, Dynatronics Corporation is evaluating transitioning production of therapeutic modalities from contract manufacturers to internal operations to enhance quality control and reduce costs.

The value is reinforced by trusted, established brands in the physical medicine market. The company markets its products under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Solaris, Hausmann, and PROTEAM. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024.

The financial position as of June 30, 2025, included cash and cash equivalents of $326,344 and working capital of $718,000.

• The company's market cap as of November 27, 2025, was $717.8K.
• Trailing 12-month revenue as of September 30, 2025, was $26.8M.
• The company owns a United States patent on its thermoelectric technology that remains in effect until February 2033.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Relationships

You're looking at how Dynatronics Corporation (DYNT) manages the people who buy their restorative medical products. This isn't just about selling; it's about the long-term connection, especially since the company is actively working to stabilize its operations and improve profitability, aiming for a gross profit margin of 24.7% on its $7.02 million net sales for the third quarter of fiscal year 2025.

Dedicated customer care and warranty service for manufactured products

Dynatronics Corporation backs its manufactured products with warranties, which are described as comparable to what's generally available in the industry. A key point for you to note is that historically, warranty claims have not been considered material to the business. For the full fiscal year 2025, net sales were $27.39 million, with a gross profit of $6.01 million. This suggests that the cost associated with servicing these relationships through warranty claims is relatively low compared to the overall revenue base. The company is also strategically shifting production of the majority of its therapeutic modalities in-house from contract manufacturers, which should help them enhance quality control directly, a critical component of customer satisfaction.

B2B relationship management with dealers and distributors

A significant part of Dynatronics Corporation's go-to-market strategy relies on its indirect channels. As of the last reported data, the company utilized a network of over 300 independent dealers across the United States to move products to end users. Most of these dealers purchase and take title to the products, meaning the relationship management is focused on supporting their sales efforts and ensuring product availability. The company's operational strategy is clearly tied to supporting these partners; for instance, their customer-centric focus in earlier periods led to backorder reduction and faster revenue commission for these B2B partners. The success of this channel is vital, as failure to maintain these relationships or if distributors are ineffective could harm the company's results of operations.

Here's a quick look at the revenue mix from the most recent quarter, which shows how the product categories-which these dealers move-are performing:

Product Category	Revenue (Three Months Ended Sept 30, 2025)	Percentage of Q3 Sales
Physical Therapy and Rehabilitation Products	$4,161,586	59.28%
Orthopedic Soft Bracing Products	$2,835,716	40.33%

Note that the Orthopedic Soft Bracing Products category saw a reduction in demand, which directly impacts the sales performance of the distribution network.

Leveraging strong, long-term customer relationships (CEO focus)

The executive leadership definitely emphasizes the importance of these connections. President, CEO, and CFO Brian Baker continues to leverage his strong customer and vendor relationships as a core element in shaping Dynatronics Corporation's future. This isn't just talk; the company has been actively using customer feedback to guide product development. Specifically, strategic customers are providing the company with a product road map, identifying gaps and necessary adjustments. This collaborative approach is intended to drive incremental revenue as new products are added to the portfolio, which in turn should create pull-through revenue for existing products. The stated focus for the fiscal year was to strengthen customer relationships while improving operating profitability.

Standardized service model through service sites in three US states

Dynatronics Corporation maintains a physical presence for service and operations across key geographic locations. They operate manufacturing facilities in Utah, New Jersey, and Minnesota. While the search results confirm these locations, they are primarily noted as manufacturing sites, and the company states that its warranty service is managed through these sites. This physical footprint supports the standardized service model, ensuring that the company has control over the manufacturing of approximately 98% of its total product sales, whether produced internally or via contract manufacturers. The company has 16,048,734 shares of common stock outstanding as of November 12, 2025, and while not a direct relationship metric, the operational stability supported by these sites is crucial for maintaining investor and customer confidence.

The primary customer base that interacts with these service and sales channels includes:

• Orthopedists and sports medicine practitioners
• Physical therapists and chiropractors
• Athletic trainers
• Clinics and hospitals
• Professional sports teams and universities
• Retail distributors and OEM partners

The company's direct sales efforts also involve agreements with regional and national chains of physical therapy clinics and hospitals, as well as group purchasing organizations (GPOs). You should keep an eye on how the internal transition of therapeutic modalities production impacts service response times going forward, as this directly affects customer confidence.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Channels

You're looking at how Dynatronics Corporation (DYNT) gets its medical products-like orthopedic soft bracing and physical therapy gear-into the hands of the practitioners who use them. The channel strategy relies heavily on intermediaries, though direct sales to larger entities are a known pressure point.

Exclusive sales through a network of dealers and distributors form the backbone of product movement. Dynatronics Corporation sells its products to a wide array of customers, including orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, all facilitated through a network of independent dealers. This network is key for market reach across the United States.

Direct sales to OEM customers (though volume is decreasing) represent a segment facing headwinds. For the fiscal year ending June 30, 2025, Net Sales were reported at $27.39 million, which was a decrease of 15.8% from the prior year, with the decline attributed in part to a reduction in overall volume for OEM customers. This trend continued into the third quarter of 2025, where Net Sales were $7.02 million, a 7.6% decrease year-over-year, again citing a reduction in volume for OEM customers. This indicates a near-term challenge in the direct-to-manufacturer channel.

Retail distributors for certain product lines are explicitly mentioned as part of the customer base served via the dealer network. While specific revenue attributed only to retail distributors isn't broken out, the overall product mix shows the relative size of the main categories moving through these channels. For the three months ended September 30, 2025, the revenue split between the two main product categories was:

Product Category	Revenue (Three Months Ended 9/30/2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

It's important to note that across fiscal years 2025 and 2024, no single product line accounted for more than 10% of total revenues, suggesting a diversified, albeit low-volume per-SKU, distribution strategy.

Company website and investor relations for corporate communication serve as the direct channel for financial stakeholders. You can track official updates via the Investor Relations section on the Dynatronics Corporation website. For instance, the Form 10-Q for the period ending September 30, 2025, was expected to be filed within a five-calendar-day extension period, as notified on November 17, 2025. The company reports its financial results, such as the Q3 FY2024 results released on May 9, 2024.

The primary customer types interacting with the distribution network include:

• Orthopedists
• Physical therapists
• Chiropractors
• Athletic trainers
• Sports medicine practitioners
• Clinics and hospitals

Dynatronics Corporation (DYNT) - Canvas Business Model: Customer Segments

You're looking at the core groups that buy products from Dynatronics Corporation as of late 2025. The company designs, manufactures, and markets its restorative products to a mix of clinical, athletic, and business-to-business channels. The customer base is geographically spread across the United States, Asia, Latin America, the Middle East, and other international locations.

The primary professional end-users are clearly defined:

• Physical therapists, orthopedists, and chiropractors
• Athletic trainers and sports medicine practitioners
• Clinics, hospitals, and rehabilitation facilities

Dynatronics Corporation also serves institutional and specialized athletic segments:

• Professional sports teams and university athletic programs

The company also sells to other businesses, specifically OEM customers (Original Equipment Manufacturers), which has shown a recent financial impact. For the three months ended September 30, 2025, Net Sales were $7.02 million. This represented a 7.6% decrease compared to the same period last year, which the company explicitly linked to a reduction in overall volume for OEM customers and softer demand in the orthopedic soft bracing category.

For the full fiscal year ending June 30, 2025, Dynatronics Corporation reported total Net Sales of $27.39 million, a decrease of 15.80% from the prior year's $32.53 million. This overall revenue decline was also attributed in part to the reduction in volume from OEM customers.

While direct revenue attribution by the listed professional segments isn't published, the product revenue split for the three months ended September 30, 2025, gives you an idea of what these segments are buying:

Product Category	Revenue (Three Months Ended September 30, 2025)
Physical Therapy and Rehabilitation Products	$4,161,586
Orthopedic Soft Bracing Products	$2,835,716

The company also markets and sells its products through retail distributors. The total number of shares outstanding as of November 12, 2025, was 16,048,734 common shares. This is the backdrop against which these customer segments operate.

Here is a summary of the identified customer types:

Customer Segment Category	Specific Examples/Notes
Clinical Professionals	Orthopedists, physical therapists, chiropractors
Athletic/Rehab Professionals	Athletic trainers, sports medicine practitioners
Facilities	Clinics, hospitals, rehabilitation facilities
Institutional/Team Sales	Professional sports teams, universities
Business-to-Business	OEM customers (volume reduction impacted FY 2025 sales)

The company also sells through retail distributors.

Dynatronics Corporation (DYNT) - Canvas Business Model: Cost Structure

You're looking at the hard numbers driving Dynatronics Corporation's operational expenses as of late 2025. Honestly, the cost structure is heavily influenced by non-operating charges right now, but the core operating costs tell a clear story of margin pressure and recent cost-cutting.

Cost of Goods Sold (COGS) is high; Gross Profit was only 21.9% of Net Sales in FY2025

The cost to make and deliver products is eating up the lion's share of revenue. For the fiscal year ended June 30, 2025, Dynatronics Corporation reported a Gross Profit of just 21.9% of Net Sales. This means that COGS represented approximately 78.1% of every sales dollar. To be fair, this low margin percentage was down from 23.5% of net sales in the prior fiscal year 2024. That compression is a major focus area for the cost structure.

Manufacturing and production costs (shifting from contract to internal)

While the specific cost breakdown related to the shift from contract manufacturing to internal production isn't itemized separately from COGS in the summary data, the low resulting gross margin percentage suggests that the current production setup-whether internal or contract-is inherently costly relative to current pricing. The strategic imperative here is clearly margin improvement, which hinges on optimizing these manufacturing and supply chain costs.

Selling, General, and Administrative (SG&A) expenses (currently being reduced)

On the overhead side, Dynatronics Corporation has made tangible progress in trimming fixed costs. SG&A expenses for the year ended June 30, 2025, were $8,464,000. That's a reduction of $1,444,000, or 14.6%, compared to the $9,908,000 recorded in fiscal year 2024. That's a solid cut, showing management is actively working to lower the operating expense base.

Here's a quick look at the key expense components for the most recent full fiscal year:

Cost/Expense Category	FY2025 Amount (Year Ended 6/30/2025)	FY2024 Amount (Year Ended 6/30/2024)
Gross Profit	$6,011,000	$7,635,000
Gross Profit as % of Net Sales	21.9%	23.5%
SG&A Expenses	$8,464,000	$9,908,000
Interest Expense, Net	$410,000	$418,000

Interest expense on debt, which was $67,207 in Q1 FY2026

Financing costs are a component of the overall cost structure. For the first quarter of fiscal year 2026, the reported interest expense was $67,207. [cite: User provided figure] This follows a trend of slight reduction, as the full fiscal year 2025 interest expense, net, was $410,000, down from $418,000 in fiscal year 2024. Lower debt balances are helping to keep this cost down.

Impairment charges, which drove the $10.90 million Net Loss in FY2025

The most significant driver of the bottom-line result was non-cash impairment charges. The Net Loss for fiscal year 2025 ballooned to $10,902,000, a sharp increase from the $2,698,000 net loss reported in FY2024. This was not an operating issue, but a significant write-down event. The total impairment charges recorded in FY2025 were substantial:

• Goodwill impairment charge: $7,117,000
• Intangible asset impairment charge: $950,000

These two items alone account for $8,067,000 of the total loss. The net loss attributable to common stockholders was even higher at $11,604,000 for FY2025.

Finance: draft 13-week cash view by Friday.

Dynatronics Corporation (DYNT) - Canvas Business Model: Revenue Streams

You're looking at the core ways Dynatronics Corporation brings in money, which is crucial for understanding its financial health as of late 2025. The primary revenue stream is product sales across its two main categories: Physical Therapy and Rehabilitation Products, and Orthopedic Soft Bracing Products.

For the full fiscal year 2025, Dynatronics Corporation reported total Net Sales of $27.39 million. That figure represented a 15.8% decrease from the prior year, which the company attributed to two main factors affecting revenue generation. One factor was a reduction in overall volume from OEM customers, and the other was a general softening in demand specifically within the orthopedic soft bracing product category. That's a tough environment to navigate, honestly.

To give you a clearer picture of the most recent performance, here's the breakdown for the first quarter of fiscal year 2026 (the three months ended September 30, 2025):

Revenue Stream Component	Q1 FY2026 Revenue Amount
Sales of Physical Therapy and Rehabilitation Products	$4,161,586
Sales of Orthopedic Soft Bracing Products	$2,835,716

If you add those two segments together, you get $7,001,902 in sales for that quarter, which aligns with the reported Q1 FY2026 sales of $7.02 million. See? The math checks out.

The dependency on Revenue from OEM customer volume is a significant factor in the revenue stream volatility you see in the numbers. The reports from late 2025 clearly indicate that a reduction in this OEM volume was a primary driver behind the decrease in both the Q3 FY2025 net sales and the full-year FY2025 net sales. This suggests that a portion of Dynatronics Corporation's revenue is tied to the ordering patterns and success of its original equipment manufacturer partners.

Another element feeding into the top line is the Sales of manufactured capital equipment and supplies. While specific revenue figures for only manufactured goods versus distributed goods for FY2025 aren't explicitly broken out in the latest reports, the company is actively working to change its production mix. Dynatronics Corporation is in the process of transitioning the production of the majority of its therapeutic modalities from contract manufacturers to internal operations. The goal here is to capture more margin by eliminating third-party markups and to gain better control over the supply chain, which directly impacts the cost side of the revenue equation.

The revenue streams for Dynatronics Corporation can be summarized by the key product areas contributing to sales:

• Physical Therapy and Rehabilitation Products
• Orthopedic Soft Bracing Products
• Sales derived from OEM customer volume
• Sales of internally manufactured equipment and supplies

The company's product portfolio is broad, covering orthopedic soft bracing, physical therapy and rehabilitation products, therapeutic modalities, and treatment tables. No single product accounted for more than 10% of total revenues in fiscal years 2025 or 2024. Finance: draft 13-week cash view by Friday.